Record metals volumes put CME Group’s core business in focus

CME Group (CME) just set a new single day record in metals futures and options volume, with heavy interest in precious metals contracts and a planned 100 Ounce Silver futures launch bringing new attention to the stock.

CME Group’s recent metals volume record and new 100 Ounce Silver futures come as the share price sits at US$289.06, with a 30 day share price return of 7.19% and a 1 year total shareholder return of 24.54%. This points to momentum that has been building over the past few years, given the 3 year total shareholder return of 83.10%.

If the surge in trading activity has your attention, it could be a good moment to see what else is moving and uncover fast growing stocks with high insider ownership.

With CME shares near their price target and recent returns already strong, the key question now is whether current trading volumes and new products leave any undervaluation, or if the market is already pricing in future growth.

Most Popular Narrative: 0.5% Undervalued

With CME Group at $289.06 against a narrative fair value of $290.40, the current setup hinges on how future trading activity and margins play out.

The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

Curious what earnings path and margin profile sit behind that close fair value call? The narrative leans on measured growth, firm profitability, and a richer future multiple.

Result: Fair Value of $290.40 (UNDERVALUED)

However, you still need to weigh the risk that lower market volatility or new DeFi style venues could pull trading activity and pressure CME’s volumes and fees.

Another Take On Valuation

While the narrative fair value pegs CME Group as about 0.5% undervalued, the SWS DCF model paints a different picture. With our DCF value at $206.94 versus the $289.06 share price, the stock screens as overvalued on this measure. This raises the question: which lens should investors consider more closely?

Build Your Own CME Group Narrative

If you look at the numbers and reach a different conclusion, or simply prefer to test your own assumptions, you can build a complete view in minutes with Do it your way.

A great starting point for your CME Group research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If CME Group has sharpened your focus, do not stop here. Broaden your watchlist with fresh angles that could surface opportunities you have not considered yet.

• Target potential mispricings by checking out these 875 undervalued stocks based on cash flows that align with your return and risk preferences.
• Ride structural trends in computing by scanning these 22 quantum computing stocks that may benefit from long term adoption of advanced technologies.
• Strengthen your income watchlist by reviewing these 12 dividend stocks with yields > 3% that offer yields above 3% as part of a diversified portfolio.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.